We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Expanding Horizons in Battlefield Injury and Regenerative Medicine

By HospiMedica staff writers
Posted on 27 May 2008
A United States national project will be dedicated to use the science of regenerative medicine to develop new treatments for wounded soldiers.

A new research institute, to be called the Armed Forces Institute for Regenerative Medicine (AFIRM), will be dedicated to repairing battlefield injuries through the use of regenerative medicine, a field of medical science that takes advantage of the body's natural healing powers to restore or replace damaged tissue and organs. More...
The new program, funded by the U.S. federal government, will also benefit the civilian population with burns or severe trauma due to illness or injury. AFIRM will be staffed by members of the U.S. Army Institute of Surgical Research (Fort Sam Houston, TX, USA) and researchers of the University of Pittsburgh (Pitt, PA, USA) and Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA). Another team will be led by Rutgers University (New Brunswick, NJ, USA) and the Cleveland Clinic (OH, USA).

"Our goal is to use our position as the international leader in developing restorative therapies for battlefield trauma to improve the outcomes for our wounded,” said designated co-director of AFIRM Alan J. Russell, Ph.D., director of the McGowan Institute for Regenerative Medicine at Pitt and founding president of the Tissue Engineering and Regenerative Medicine International Society (TERMIS). "Our ability to provide these treatments is in part due to our team's long experience in this field and our broad pipeline of technologies.”

AFIRM will have multiple research teams working in several fields, including burn repair, wound healing without scarring, craniofacial reconstruction, limb reconstruction, regeneration or transplantation, and compartment syndrome - a condition related to inflammation after surgery or injury that can lead to increased pressure, impaired blood flow, nerve damage, and muscle death.

"For the first time in the history of regenerative medicine, we have the opportunity to bring transformational technologies to wounded soldiers, and to do so in partnership with the armed services,” said designated co-director of AFIRM Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine. "This field of science has the potential to significantly impact our ability to successfully treat major trauma.”

Government sponsors of AFIRM are the U.S. Army Medical Research and Materiel Command, the U.S. Office of Naval Research, the U.S. Air Force, and the U.S. National Institutes of Health (NIH). In addition to the announced government funding, the universities involved and the other partners will provide more than US$180 million from academic institutions, industry and state and federal agencies for the projects – for more than $250 million available for regeneration research.


Related Links:
U.S. Army Institute of Surgical Research
University of Pittsburgh
Wake Forest University Baptist Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.